The influence of metabolic syndrome on the development and clinical manifestations of benign prostatic hyperplasia
Benign prostatic hyperplasia (BPH) — one of the most common urological diseases that lead to the development of symptoms of the lower urinary tract (SLUT). BPH-multifactorial disease, in which a significant role is given to increase the activity of the enzyme 5a-reductase and hormonal imbalance asso...
Saved in:
Main Authors: | V. B. Filimonov, R. V. Vasin, A. A. Kostin, V. N. Panchenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
QUASAR, LLC
2018-12-01
|
Series: | Исследования и практика в медицине |
Subjects: | |
Online Access: | https://www.rpmj.ru/rpmj/article/view/321 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Features of conservative therapy of benign prostatic hyperplasia in patients with metabolic syndrome: " Treat to Target "
by: V. B. Filimonov, et al.
Published: (2020-12-01) -
Assessment of novel biomarkers of renal dysfunction associated with lower urinary tract symptoms in men with benign prostatic hyperplasia
by: V. Yu. Startsev, et al.
Published: (2024-11-01) -
Prostatic Artery Embolization for Benign Prostatic Hyperplasia—A Primer for Interventional Radiologists
by: Tiago Bilhim, et al.
Published: (2021-07-01) -
Endoscopic Treatment of Prostatic Hyperplasia in Elderly Patients: A Comparative Analysis of Resection and Enucleation Technique
by: K. S. Peshekhonov, et al.
Published: (2020-04-01) -
Overactive bladder following surgical intervention for benign prostatic hyperplasia: treatment outcomes in routine clinical practice
by: D. A. Bogdanov, et al.
Published: (2025-07-01)